Endothelin antagonism with bosentan, a dual receptor blocker, normalizes dysregulated transforming growth factor beta signaling pathways in rats with chronic heart failure

被引：0
|
作者：
Schafhalter-Zoppoth, I
Gray, MO
Teerlink, JR
机构：
[1] Univ Calif San Francisco, San Francisco, CA 94143 USA
[2] San Francisco VA Med Ctr, San Francisco, CA USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2002年 / 39卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：168A / 168A
页数：1
相关论文
共 38 条
  • [1] Endothelin antagonism with bosentan improves myocardial mechanics and ventricular remodeling in rats with chronic heart failure
    Schafhalter-Zoppoth, I
    Teerlink, JR
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (05) : 171A - 171A
  • [2] Relationship between dysregulation of the transforming growth factor beta signaling pathway and ventricular remodeling in rats with chronic heart failure
    Teerlink, JR
    Schafhaiter-Zoppoth, I
    Gao, LR
    Karliner, JS
    CIRCULATION, 2000, 102 (18) : 357 - 357
  • [3] Clinical effects of endothelin receptor antagonism with bosentan in patients with severe chronic heart failure: Results of a pilot study
    Packer, M
    Mcmurray, J
    Massie, BM
    Caspi, A
    Charlon, V
    Cohen-Solal, A
    Kiowski, W
    Kostuk, W
    Krum, H
    Levine, B
    Rizzon, P
    Soler, J
    Swedberg, K
    Anderson, S
    Demets, DL
    JOURNAL OF CARDIAC FAILURE, 2005, 11 (01) : 12 - 20
  • [4] Angiotensin II Receptor Antagonism Reduces Transforming Growth Factor Beta and Smad Signaling in Thoracic Aortic Aneurysm
    Nataatmadja, Maria
    West, Jennifer
    Prabowo, Sulistiana
    West, Malcolm
    OCHSNER JOURNAL, 2013, 13 (01): : 42 - 48
  • [5] Involvement of transforming growth factor-beta in the pathogenesis of hypertension in rats with chronic renal failure
    Lavoie, P
    Robitaille, G
    Agaharazii, M
    Lebel, M
    Larivière, R
    JOURNAL OF HYPERTENSION, 2004, 22 : S80 - S80
  • [6] Effect of paeoniflorin on cardiac remodeling in chronic heart failure rats through the transforming growth factor β1/Smad signaling pathway
    Liu, Mao
    Ai, Jiao
    Feng, Jie
    Zheng, Jiankang
    Tang, Kai
    Shuai, Zhuang
    Yang, Jingxi
    CARDIOVASCULAR DIAGNOSIS AND THERAPY, 2019, 9 (03) : 272 - +
  • [7] Long-Term Effect of Endothelin Receptor Antagonism With Bosentan on the Morbidity and Mortality of Patients With Severe Chronic Heart Failure Primary Results of the ENABLE Trials
    Packer, Milton
    McMurray, John J. V.
    Krum, Henry
    Kiowski, Wolfgang
    Massie, Barry M.
    Caspi, Avi
    Pratt, Craig M.
    Petrie, Mark C.
    DeMets, David
    Kobrin, Isaac
    Roux, Sebastien
    Swedberg, Karl
    JACC-HEART FAILURE, 2017, 5 (05) : 317 - 326
  • [8] Transforming growth factor beta 1-new chronic ischaemic heart failure decompensation marker?
    Dabek, J.
    Piechota, M.
    Majewski, M.
    EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 : 342 - 342
  • [9] Angiogenesis in Patients with Chronic Heart Failure: Focus on Endothelial Vascular Growth Factor, Pentraxin-3 and Transforming Growth Factor Beta
    Shepel, Ruslan N.
    Drapkina, Oxana M.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2020, 16 (03) : 439 - 448
  • [10] ROLE OF ENDOTHELIN IN THE MAINTENANCE OF BLOOD-PRESSURE IN CONSCIOUS RATS WITH CHRONIC HEART-FAILURE - ACUTE EFFECTS OF THE ENDOTHELIN RECEPTOR ANTAGONIST RO-47-0203 (BOSENTAN)
    TEERLINK, JR
    LOFFLER, BM
    HESS, P
    MAIRE, JP
    CLOZEL, M
    CLOZEL, JP
    CIRCULATION, 1994, 90 (05) : 2510 - 2518
1234